As of Dec 15
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Spero Therapeutics Inc have a median target of 26.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +140.30% increase from the last price of 10.82.
The current consensus among 4 polled investment analysts is to Buy stock in Spero Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.